Back to results
US 6,475,732 B1Granted
Genetic alterations associated with cancer
AssigneeThe Regents of the University of California
InventorsLaleh Shayesteh, Joe W. Gray
Life of this patent
Estimating the term…
Abstract
The present invention provides new probes for the detection of chromosomal alterations associated with cancer, particularly ovarian cancer. The probes bind selectively with target nucleic acid sequences at 3q26.
Claims10
A method of screening for the presence of increased DNA copy number associated with cancer, the method comprising:
- contacting a nucleic acid sample comprising genomic DNA from a human patient with a probe which binds selectively to a target nucleic acid sequence at 3q26.3, wherein the target nucleic acid sequence is in a GLUT2 gene, and the probe is contacted with the sample under conditions in which the probe binds selectively with the target nucleic acid sequence to form a stable hybridization complex;
- and
- detecting the formation of a hybridization complex, wherein the amount of hybridization complex is increased relative to normal, thereby detecting the presence of DNA copy number changes associated with cancer.
Dependencies are inferred from the claim text.